Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANITA: Nintedanib vs Ifosfamide in Advanced Soft Tissue Sarcoma
NCT02808247Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2017
- Primary completion
- Nov 2020
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 2 trial of nintedanib in soft tissue sarcoma (STS), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 2017; status: terminated.
02
Drugs
nintedanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02808247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02808247.